Morris J, Wishka D G, Lin A H, Humphrey W R, Wiltse A L, Gammill R B, Judge T M, Bisaha S N, Olds N L, Jacob C S
Upjohn Laboratories, Upjohn Company, Kalamazoo, Michigan 49001.
J Med Chem. 1993 Jul 9;36(14):2026-32. doi: 10.1021/jm00066a012.
The synthesis and biological evaluation of a series of antiplatelet 2-morpholinylchromones has been described. Modification of the C-7 phenylmethoxy group of 8-methyl-7-(phenylmethoxy)-2-(4-morpholinyl)-4H-1-benzopyran-4-one (2) has led to the discovery of a series of 7-[(amino-ethyl)oxy]-8-methyl derivatives which are potent inhibitors of ADP-induced platelet aggregation. Several members of this class proved active in preventing platelet-dependent thrombus formation in the dog, including 8-methyl-7-[2-(4-methyl-1-piperazinyl)ethoxy]-2-(4- morpholinyl)-4H-1-benzopyran-4-one (39) which was devoid of hemodynamic effects at the effective antithrombotic dose.
已描述了一系列抗血小板2-吗啉基色酮的合成及生物学评价。对8-甲基-7-(苯甲氧基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮(2)的C-7苯甲氧基进行修饰,从而发现了一系列7-[(氨基乙基)氧基]-8-甲基衍生物,这些衍生物是二磷酸腺苷(ADP)诱导的血小板聚集的有效抑制剂。这类化合物中的几个成员在预防犬类血小板依赖性血栓形成方面被证明具有活性,包括8-甲基-7-[2-(4-甲基-1-哌嗪基)乙氧基]-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮(39),其在有效抗血栓剂量下没有血流动力学效应。